Navigation Links
New therapy for heart failure may enhance body's stem cell response at cardiovascular injury site
Date:2/21/2013

l is unique in that it uses gene therapy to turn on a process leading to cell regeneration rather than simply administering stem cells directly."

The Pepin Heart Institute has a history of cardiovascular stem cell research as part of the NIH sponsored Cardiac Cell Therapy Research Network (CCTRN) as well as other active cell therapy trials. Locally, the STOP-HF trial is the first of several regenerative medicine clinical trials teaming the USF Heart Institute with Florida Hospital Pepin Heart Institute, which is adjacent to the USF Health campus.

"This is the beginning of a new era in cardiovascular therapies," said Dr. Leslie Miller, national principal investigator for the STOP-HF trial and professor of cardiovascualar sciences at the USF Health Morsani College of Medicine. "Targeted gene and cell therapies delivered directly into the heart hold promise for helping to regenerate tissue, reduce injury and restore heart function. USF Health, working with our partners, will find new ways to diagnose and treat patients, with the aim of reducing and ultimately harnessing the global impact of heart disease."

The trial, sponsored by Juventas Therapeutics, is a double blind, randomized, placebo-controlled Phase II study evaluating the safety and effectiveness of JVS-100 in patients with ischemic heart failure. JVS-100 is the name of the gene therapy that directs the heart muscle to produce Stromal cell-Derived Factor 1 (SDF-1), a protein that has been shown to repair damaged tissue in the body through the recruitment of circulating stem cells to the site of injury, prevention of ongoing cell death and restoration of blood flow.

Earlier this year, Juventas reported results from its Phase I study in Class III ischemic heart failure patients. In addition to meeting the primary safety endpoint, patients in the study who received the drug demonstrated clinically significant improvements in exercise levels at the 12 month mark. '/>"/>

Contact: Anne DeLotto Baier
abaier@health.usf.edu
813-974-3303
University of South Florida (USF Health)
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Cell therapy a little more concrete thanks to VIB research
2. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
3. Novel coronavirus well-adapted to humans, susceptible to immunotherapy
4. Experimental gene therapy treatment for Duchenne muscular dystrophy offers hope for youngster
5. Compound stimulates tumor-fighting protein in cancer therapy
6. VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers, 2013
7. Pitt researchers reveal mechanism to halt cancer cell growth, discover potential therapy
8. Changes to DNA on-off switches affect cells ability to repair breaks, respond to chemotherapy
9. BUSM study shows potential of differentiated iPS cells in cell therapy without immune rejection
10. Canada launches first gene therapy trial for Fabry disease
11. New way to kill lymphoma without chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New therapy for heart failure may enhance body's stem cell response at cardiovascular injury site
(Date:8/28/2014)... is needed to ensure safeguards are in place to ... PLOS ONE , researchers from Monash University, Stellenbosch University ... results from different studies - to look at the ... determine whether they actually protect biodiversity. , Dr ... area from human exploitation made common sense, however, up ...
(Date:8/27/2014)... -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced that it ... units of common stock and warrants at a price ... million, prior to deducting underwriting discounts and commissions and ... warrants are immediately separable and will be issued separately.  ... consists of 2,000 shares of common stock and 2,000 ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Law Enforcement ... http://www.reportlinker.com/p02316674/Law-Enforcement-Biometrics-Market-in-North-America-2014-2018.html About Biometrics ... individuals on the basis of their physical or ... of both physiological traits such as fingerprints, face ...
Breaking Biology News(10 mins):Protected areas proven to protect biodiversity 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Law Enforcement Biometrics Market in North America 2014-2018 2Law Enforcement Biometrics Market in North America 2014-2018 3Law Enforcement Biometrics Market in North America 2014-2018 4Law Enforcement Biometrics Market in North America 2014-2018 5
... 20, 2011 Whether engaging experts from the outside to ... AIDS, leaders around the globe acknowledge the need to innovate ... facing business and society today. NineSigma, the leading provider of ... the imperative to innovate for organizations is greater than ever, ...
... Gulf of Mexico is safe to eat after the Deepwater ... testing program that continues more than a year after the ... by Federal agencies to assure safety of Gulf seafood is ... of Chemical & Engineering News (C&EN), ACS,s weekly news magazine. ...
... A new genus and species of hadrosaur (duck-billed) dinosaur ... has been named by scientists who expect the ... most striking feature of Acristavus gagslarsoni , the ... head lacked the distinctive ornamentation common to later duck-billed ...
Cached Biology News:NineSigma Declares "Innovate or Die" Is the Mantra for Business Success 2NineSigma Declares "Innovate or Die" Is the Mantra for Business Success 3NineSigma Declares "Innovate or Die" Is the Mantra for Business Success 4New duck-billed dinosaur gives scientists clues to evolution of head ornamentation and provinciality 2
(Date:8/28/2014)... , Aug. 28, 2014 ... a new market research report ... Whole Exome Sequencing ... (Library Preparation, Target Enrichment), by ... by Synthesis), by Application (Cancer, ...
(Date:8/28/2014)... 2014   SunTrust Robinson Humphrey (STRH) ... to its equity research team in biotechnology and ... in equity research demonstrates our commitment to providing ... enhance their investment decision making," said Biff ... continue to make significant investments in differentiated content ...
(Date:8/28/2014)... Exciting new work by a Florida State University research ... can take your temperature, emit white light, and convert ... molecule looks like a butterfly. , Biwu Ma, associate ... in the FAMU-FSU College of Engineering, created the molecule ... continued to discover that his creation has many other ...
(Date:8/28/2014)... August 28, 2014 Earlier this month, ... in partnership with the U.S. Air Force on ... The results indicated that this type of fuel made ... and will be important to America’s Eco friendly future. ... has a mandate to become independent of foreign oil ...
Breaking Biology Technology:Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 2Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 3Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 4Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 5Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 6Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 7Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 8Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 9Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 10Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 11Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 12Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 13SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5
... business delivers record growth; biofuels business, advancing ... Mass., May 5 Verenium Corporation,(Nasdaq: VRNM ... cellulosic,ethanol and high-performance specialty enzymes, today reported financial,results ... updated 2008 financial,guidance., "I am encouraged by ...
... 37.5% to $14.8 Million ... ... Guidance, MINNEAPOLIS, May 5 ATS Medical, Inc. (Nasdaq:,ATSI), manufacturer ... results for the first,quarter ended March 29, 2008. Revenue for the ...
... May 5 Assay Designs, Inc., a leading,provider ... life sciences,and translational research markets, announced a collaboration ... University of South Carolina and,Dr. Jennifer Isaacs, laboratory. ... provide anti-Heat shock protein 90 (Hsp90) antibody for ...
Cached Biology Technology:Verenium Reports Financial Results for the First Quarter 2008 2Verenium Reports Financial Results for the First Quarter 2008 3Verenium Reports Financial Results for the First Quarter 2008 4Verenium Reports Financial Results for the First Quarter 2008 5Verenium Reports Financial Results for the First Quarter 2008 6Verenium Reports Financial Results for the First Quarter 2008 7Verenium Reports Financial Results for the First Quarter 2008 8Verenium Reports Financial Results for the First Quarter 2008 9Verenium Reports Financial Results for the First Quarter 2008 10Verenium Reports Financial Results for the First Quarter 2008 11ATS Medical Announces Record Quarterly Revenue and Gross Profit 2ATS Medical Announces Record Quarterly Revenue and Gross Profit 3ATS Medical Announces Record Quarterly Revenue and Gross Profit 4ATS Medical Announces Record Quarterly Revenue and Gross Profit 5ATS Medical Announces Record Quarterly Revenue and Gross Profit 6ATS Medical Announces Record Quarterly Revenue and Gross Profit 7ATS Medical Announces Record Quarterly Revenue and Gross Profit 8ATS Medical Announces Record Quarterly Revenue and Gross Profit 9Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC) 2
Canine Chondrocytes (CnC) (500,000 cells)...
... brings together UV irradiation and antimicrobial stainless ... PCR contamination! Quickly inactivate DNA between ... clean environment with antimicrobial coated stainless steel ... minutes with built-in 30-minute timer ...
B-FABP (FL-132)...
... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
Biology Products: